Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
Ling ZhangXiaojuan ZhangHaitao ZhangFeng LiuYanghui BiYanyan ZhangCaixia ChengJing LiuPublished in: Breast cancer (Tokyo, Japan) (2020)
Our study suggests that SF3B1 may be an important molecular target for breast cancer treatment and provides a new clue for clinical treatment of breast cancer.